Levetiracetam Stada

Levetiracetam, the active ingredient in Levetiracetam Stada, is an antiepileptic presented as an oral tablet for oral use. It is employed to control various seizure types in patients with epilepsy. GNH USA supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. - Epilepsy: helps achieve seizure control across multiple seizure types. - Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: lowers the occurrence of convulsive episodes.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate pain in the head region. - Nausea: occasional upset stomach or urge to vomit. - Irritability: changes in mood or increased agitation. - Somnolence: tendency to feel sleepy during the day.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: low white blood cells or platelets. - Hepatic dysfunction: signs of liver injury such as jaundice. - Stevens‑Johnson syndrome: severe skin blistering. - Multi‑organ hypersensitivity: systemic inflammatory response.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose if creatinine clearance is reduced. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy: discuss potential risks with a healthcare professional. - Lactation: evaluate benefits versus possible infant exposure. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels, reducing seizure control. - Phenobarbital: can decrease levetiracetam exposure, necessitating dose adjustment.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations, watch for side effects. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception. - Antidepressants (SSRIs): monitor for additive central nervous system effects. - Immunosuppressants (e.g., cyclosporine): observe for altered drug levels. - Alcohol: increased sedation and dizziness may occur.